Meta Pixel

News and Announcements

Sydney Emerging Company Showcase February 2017

  • Published February 07, 2017 4:36PM UTC
  • Publisher Wholesale Investor
  • Categories Events

After successfully hosting 27+ investor events across 6 countries in the last 12 months, Wholesale Investor are proud to be hosting our first 2017 investor event in conjunction with Wild Digital, The Sydney Emerging Company Showcase, on Tuesday 21st of February 2017.

Join over 200 sophisticated and professional investors, brokers, fund managers and family offices as you discover leading emerging growth companies across a range of sectors and gain access to exclusive networking sessions with the participating companies.

Showcase Highlights:

  • Live Presentations from Private, Pre-IPO and IPO companies
  • Pre & post-event networking sessions
  • Access to unseen investment opportunities

This event is proudly sponsored by Investec, PwC, DLA Piper, NZTE, BMYG and World First.

For more information please click here.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now